Drug recall · October 5, 2022
Ampicillin for Injection recall
Why: Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A
- Lots / codes
Lot 7105130, exp 9/2023
- Quantity
- 3,931 cartons
- Company
- Viatris Inc, Canonsburg, PA
- Distribution
- Nationwide in the USA
- Initiated
- September 21, 2022 · Voluntary: Firm initiated
- Classified
- September 23, 2022
- Reported
- October 5, 2022
- Ended
- October 31, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ampicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.